BioScrip, Inc. (NASDAQ: BIOS) reported Q2 EPS of ($0.07), $0.06 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $155.9 million versus the consensus estimate of $153.76 million.

For earnings history and earnings-related data on BioScrip, Inc. (BIOS) click here.

Earnings